跳至主要内容
临床试验/NCT03905759
NCT03905759Unknown2 期

Preoperative Colchicine, Dronedarone Or Amiodarone for Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG; A Comparative Study

doaa rashwan1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2019年4月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
48
试验地点
1
主要终点
AF

研究概览

简要总结

Atrial fibrillation in the postoperative period of myocardial revascularization surgery (AF-POMR) occurs in 10% to 65% of patients, increasing morbidity and mortality after surgery. is associated with an increase in hospital length of stay, and, thus, in costs,and can cause serious clinical complications, such as hypotension, heart failure, stroke and other thromboembolic disorders.Although not completely understood, the electrophysiological mechanism of AF-POMR is believed to be reentry.

详细描述

Aim of the study The aim of this work is to study the effect of preoperative Colchicine, Dronedarone or Amiodarone for prophylaxis against postoperative atrial fibrillation in patients undergoing on-pump CABG.

Patients and Methods

Type and site of the study:

This randomized double blinded clinical study will be carried out at Beni-Suef university hospital, after approval by the department of Anesthesiology, Pain management and Surgical ICU, the local ethics and research committee and other involved departments, faculty of medicine, Beni-Suef University.

Study population:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • The study population will include inpatients of the cardiothoracic department scheduled for CABG surgery, both sex, selected randomly according to American Society of Anesthesiologists(ASA) grade II and III

排除标准

  • - Liver dysfunction, pregnancy.
  • History of allergic reaction to any drug used in this study.
  • Emergency procedure
  • Preoperative dialysis
  • Patients on antiarrhythmic medications

研究组 & 干预措施

colchicine

Active Comparator

Colchicine will be used at the dose of 1 mg orally, twice daily, preoperatively (1 days), and of 0.5 mg, twice daily, until hospital discharge

干预措施: Colchicine (Drug)

Dronedarone

Active Comparator

Dronedarone (200 mg twice daily starting from day before operation till 5 days after)

干预措施: Dronedarone (Drug)

amiodarone

Active Comparator

amiodarone (200 mg three times per day)21 administered 6 days prior to surgery through 6 days after surgery

干预措施: Amiodarone (Drug)

结局指标

主要结局

AF

时间窗: change from baseline rhythm at 6 days

incidence of AF

次要结局

未报告次要终点

研究者

发起方
doaa rashwan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

doaa rashwan

Assistant profesor Doaa Rashwan

Beni-Suef University

研究点 (1)

Loading locations...

相似试验